Sunday, November 8, 2026

USD/CNH Went Down By Over 1% In The Last 10 Sessions

ViaNews Editorial Team

January 16, 2024

USD/CNH Went Down By Over 1% In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 1.3% for the last 10 sessions. At 06:09 EST on Tuesday, 16 January, USD/CNH (USDCNH) is $7.22.

USD/CNH's yearly highs and lows, it's 0.497% up from its 52-week low and 0.024% down from its 52-week high.

News about

  • Usd/jpy forecast: usd/jpy continues to see volatility on Friday - 15 January 2024. According to DailyForex on Monday, 15 January, "At the end of the day, the USD/JPY currency pair experienced a downturn in response to the weaker PPI data. ", "Despite this setback, there are several crucial factors to consider in the USD/JPY currency pair."
  • Usd/jpy will struggle to hold above 146/147 levels – ING. According to FXStreet on Monday, 15 January, "We think 152 probably was the top for USD/JPY and it will struggle to hold above 146/147 levels now. "
  • Usd/jpy climbs in light trading and faces resistance at around 146.00. According to FXStreet on Monday, 15 January, "Despite that, the Greenback (USD) remains strong across the board, as the USD/JPY exchanges hands at 145.79, up by 0.63%.", "The daily chart portrays the pair at the brisk of shifting bullish, as the USD/JPY spot price is near the bottom of the Ichimoku Cloud (Kumo). "
  • Usd/jpy holds above 145.00 despite weaker US dollar. According to FXStreet on Monday, 15 January, "This, in turn, might cap the upside of the Greenback and act as a headwind for the USD/JPY pair. ", "The USD/JPY pair gained traction above the 145.00 mark during the early Asian session on Monday. "
  • Usd/jpy gathers strength under the 146.00 barrier on the renewed US dollar demand. According to FXStreet on Tuesday, 16 January, "The USD/JPY pair holds positive ground below the 146.00 barrier during the early Asian session on Tuesday. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com